Abstract
In its mammalian host, the kinetoplastid protozoan parasite, Trypanosoma cruzi, is obliged to establish intracellular residence in order to replicate. This parasite can infect and replicate within a diverse array of cell and tissue types across many mammalian host species. The establishment of quantitative assays to assess the replicative capacity of intracellular T. cruzi amastigotes under different conditions is a critical facet to understanding this host–pathogen interaction. Several complementary methods are outlined here. Their strengths and deficiencies in quantifying intracellular amastigote growth and death are discussed. We describe three assays to assess growth/replication. (1) A high throughput multiplexed plate-based assay that quantifies both host cell and parasite abundance. This method allows for the rapid and simultaneous screening of many conditions (e.g., small molecule inhibitors, the impact of host gene knockdown or of altered environmental parameters). (2) Simple fluorescence microscopy-based enumeration of amastigotes within host cells and (3) flow cytometry-based quantification of amastigote proliferation following isolation from host cells. Each approach has advantages but none of these can assess lethal outcomes in a quantitative manner. For this, we describe a clonal outgrowth assay that identifies the proportion of parasites that succumb to a defined exposure. Even using these assays, it can be challenging to differentiate between direct (targeting the parasite) and/or indirect (targeting the host) effects of a given treatment on amastigote growth. Therefore, we also outline a method of purification of intracellular amastigotes that allows for downstream biochemical and metabolic investigations specifically on the isolated amastigote.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Bern C (2015) Chagas’ disease. N Engl J Med 373:456–466. https://doi.org/10.1056/NEJMra1410150
Zhang L, Tarleton RL (1999) Parasite persistence correlates with disease severity and localization in chronic Chagas’ disease. J Infect Dis 180:480–486. https://doi.org/10.1086/314889
Tarleton RL, Zhang L, Downs MO (1997) “Autoimmune rejection” of neonatal heart transplants in experimental Chagas disease is a parasite-specific response to infected host tissue. Proc Natl Acad Sci U S A 94:3932–3937
Morillo CA, Marin-Neto JA, Avezum A, Sosa-Estani S, Rassi A, Rosas F, Villena E, Quiroz R, Bonilla R, Britto C, Guhl F, Velazquez E, Bonilla L, Meeks B, Rao-Melacini P, Pogue J, Mattos A, Lazdins J, Rassi A, Connolly SJ, Yusuf S, Investigators BENEFIT (2015) Randomized trial of benznidazole for chronic Chagas’ cardiomyopathy. N Engl J Med 373:1295–1306. https://doi.org/10.1056/NEJMoa1507574
Murcia L, Carrilero B, Muñoz MJ, Iborra MA, Segovia M (2010) Usefulness of PCR for monitoring benznidazole response in patients with chronic Chagas’ disease: a prospective study in a non-disease-endemic country. J Antimicrob Chemother 65:1759–1764. https://doi.org/10.1093/jac/dkq201
Dumoulin PC, Burleigh BA (2018) Stress-induced proliferation and cell cycle plasticity of intracellular Trypanosoma cruzi amastigotes. mBio 9. https://doi.org/10.1128/mBio.00673-18
Buckner FS, Verlinde CL, La Flamme AC, Van Voorhis WC (1996) Efficient technique for screening drugs for activity against Trypanosoma cruzi using parasites expressing beta-galactosidase. Antimicrob Agents Chemother 40:2592–2597
Romanha AJ, de CSL, Soeiro M de NC, Lannes-Vieira J, Ribeiro I, Talvani A, Bourdin B, Blum B, Olivieri B, Zani C, Spadafora C, Chiari E, Chatelain E, Chaves G, Calzada JE, Bustamante JM, Freitas-Junior LH, Romero LI, Bahia MT, Lotrowska M, Soares M, Andrade SG, Armstrong T, Degrave W, Andrade Z de A (2010) In vitro and in vivo experimental models for drug screening and development for Chagas disease. Mem Inst Oswaldo Cruz 105:233–238
Peña I, Pilar Manzano M, Cantizani J, Kessler A, Alonso-Padilla J, Bardera AI, Alvarez E, Colmenarejo G, Cotillo I, Roquero I, de Dios-Anton F, Barroso V, Rodriguez A, Gray DW, Navarro M, Kumar V, Sherstnev A, Drewry DH, Brown JR, Fiandor JM, Julio Martin J (2015) New compound sets identified from high throughput phenotypic screening against three kinetoplastid parasites: an open resource. Sci Rep 5:8771. https://doi.org/10.1038/srep08771
Khare S, Nagle AS, Biggart A, Lai YH, Liang F, Davis LC, Barnes SW, Mathison CJN, Myburgh E, Gao M-Y, Gillespie JR, Liu X, Tan JL, Stinson M, Rivera IC, Ballard J, Yeh V, Groessl T, Federe G, Koh HXY, Venable JD, Bursulaya B, Shapiro M, Mishra PK, Spraggon G, Brock A, Mottram JC, Buckner FS, Rao SPS, Wen BG, Walker JR, Tuntland T, Molteni V, Glynne RJ, Supek F (2016) Proteasome inhibition for treatment of leishmaniasis, Chagas disease and sleeping sickness. Nature 537:229–233. https://doi.org/10.1038/nature19339
Diaz-Gonzalez R, Kuhlmann FM, Galan-Rodriguez C, Madeira da Silva L, Saldivia M, Karver CE, Rodriguez A, Beverley SM, Navarro M, Pollastri MP (2011) The susceptibility of trypanosomatid pathogens to PI3/mTOR kinase inhibitors affords a new opportunity for drug repurposing. PLoS Negl Trop Dis 5:e1297. https://doi.org/10.1371/journal.pntd.0001297
Bettiol E, Samanovic M, Murkin AS, Raper J, Buckner F, Rodriguez A (2009) Identification of three classes of heteroaromatic compounds with activity against intracellular Trypanosoma cruzi by chemical library screening. PLoS Negl Trop Dis 3:e384. https://doi.org/10.1371/journal.pntd.0000384
Caradonna KL, Engel JC, Jacobi D, Lee C-H, Burleigh BA (2013) Host metabolism regulates intracellular growth of Trypanosoma cruzi. Cell Host Microbe 13:108–117. https://doi.org/10.1016/j.chom.2012.11.011
Alonso-Padilla J, Cotillo I, Presa JL, Cantizani J, Peña I, Bardera AI, Martín JJ, Rodriguez A (2015) Automated high-content assay for compounds selectively toxic to Trypanosoma cruzi in a myoblastic cell line. PLoS Negl Trop Dis 9:e0003493. https://doi.org/10.1371/journal.pntd.0003493
Sykes ML, Avery VM (2015) Development and application of a sensitive, phenotypic, high-throughput image-based assay to identify compound activity against Trypanosoma cruzi amastigotes. Int J Parasitol Drugs Drug Resist 5:215–228. https://doi.org/10.1016/j.ijpddr.2015.10.001
Young RD, Rathod PK (1993) Clonal viability measurements on Plasmodium falciparum to assess in vitro schizonticidal activity of leupeptin, chloroquine, and 5-fluoroorotate. Antimicrob Agents Chemother 37:1102–1107
Shah-Simpson S, Pereira CFA, Dumoulin PC, Caradonna KL, Burleigh BA (2016) Bioenergetic profiling of Trypanosoma cruzi life stages using Seahorse extracellular flux technology. Mol Biochem Parasitol 208:91–95. https://doi.org/10.1016/j.molbiopara.2016.07.001
Shah-Simpson S, Lentini G, Dumoulin PC, Burleigh BA (2017) Modulation of host central carbon metabolism and in situ glucose uptake by intracellular Trypanosoma cruzi amastigotes. PLoS Pathog 13:e1006747. https://doi.org/10.1371/journal.ppat.1006747
Gazos-Lopes F, Martin JL, Dumoulin PC, Burleigh BA (2017) Host triacylglycerols shape the lipidome of intracellular trypanosomes and modulate their growth. PLoS Pathog 13:e1006800. https://doi.org/10.1371/journal.ppat.1006800
Marques A, Marques A, Nakayasu E, Almeida I (2011) Purification of extracellular and intracellular amastigotes of Trypanosoma cruzi from mammalian host-infected cells. Protoc Exch. https://doi.org/10.1038/protex.2011.265
Roederer M (2011) Interpretation of cellular proliferation data: avoid the panglossian. Cytom Part J Int Soc Anal Cytol 79:95–101. https://doi.org/10.1002/cyto.a.21010
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Dumoulin, P.C., Burleigh, B.A. (2020). Methods for the Investigation of Trypanosoma cruzi Amastigote Proliferation in Mammalian Host Cells. In: Michels, P., Ginger, M., Zilberstein, D. (eds) Trypanosomatids. Methods in Molecular Biology, vol 2116. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-0294-2_32
Download citation
DOI: https://doi.org/10.1007/978-1-0716-0294-2_32
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-0293-5
Online ISBN: 978-1-0716-0294-2
eBook Packages: Springer Protocols